Tag: Preventive Medicine
-
Celebrating 50 Years of the Department of Preventive Medicine
Originally founded in 1972 as a small team of fewer than 10 people, the department has grown to include seven divisions with 285 faculty and staff.
-
Evaluating Treatment Options for Peripheral Artery Disease
Telmisartan, an angiotensin receptor blocker drug, did not improve walking performance in patients with lower extremity peripheral artery disease, according to a recent clinical trial published in JAMA.
-
Investigating Heart Disease Mortality in Asian American Populations
Mortality rates for ischemic heart disease in Asian American subpopulations were found to be more burdensome than previously reported, according to a Northwestern Medicine study published in JAMA Internal Medicine.
-
Investigating Racial Differences in Multiple Myeloma
Investigators have identified distinct epigenetic pathways in African American and European American patients diagnosed with multiple myeloma, according to a Northwestern Medicine study.
-
McDermott Honored with AHA Distinguished Achievement Award
Mary M. McDermott, MD, ’92 GME, the Jeremiah Stamler Professor of Medicine in the Division of General Internal Medicine, has been honored with the American Heart Association’s 2022 Peripheral Vascular Disease Distinguished Achievement Award.
-
Investigating the Utility of Polygenic Risk Scores for CHD
Polygenic risk scores demonstrated minimal clinical benefit in predicting long-term coronary heart disease when added to a traditional risk factor model, according to a Northwestern Medicine study.
-
Epigenetic Biomarkers Predict CVD Risk
A new study provides evidence that blood epigenetic biomarkers contain “snapshots” of past cardiovascular health exposures and behavior at the molecular level.
-
Identifying Protein Interactions that Promote Cancer Growth
Proteins gain new interactions that are potentially oncogenic and could drive cancer development and growth, according to a recent study.
-
Northwestern Faculty Elected to Society for Clinical Trials Board
Jody Ciolino, PhD, and Masha Kocherginsky, PhD, faculty in the Department of Preventive Medicine Division of Biostatistics, were elected to the Board of Directors for the Society for Clinical Trials (SCT).
-
Understanding Immunosuppressive Mechanisms of T-Cell Receptors
Investigators have discovered the mechanisms underlying a T-cell receptor’s immunosuppressive function, findings that may improve the development of precision therapeutics for chronic disease, including cancer.
